This inventor holds 2 USPTO granted patents. Top assignee: Merrell Dow Pharmaceuticals. Active years: 1985-1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985-1986
Title: Shakir Sarhan: Innovator in Seizure Disorder Treatments
Introduction
Shakir Sarhan is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of seizure disorders. With a total of 2 patents to his name, Sarhan's work focuses on innovative solutions for epilepsy and related conditions.
Latest Patents
Shakir Sarhan's latest patents include groundbreaking research on the treatment of seizure disorders. His work highlights the synergistic effects of glycine, sarcosine, or N,N-dimethylglycine when combined with gamma-vinyl GABA. This combination shows promise in effectively treating seizure disorders, particularly epilepsy.
Career Highlights
Sarhan is currently associated with Merrell Dow Pharmaceuticals, where he continues to develop and refine his innovative ideas. His dedication to improving the lives of those affected by seizure disorders is evident in his research and patent filings.
Collaborations
Shakir Sarhan collaborates with esteemed professionals in his field, including Nikolaus J Seiler. Their combined expertise contributes to the advancement of pharmaceutical treatments for seizure disorders.
Conclusion
Shakir Sarhan's contributions to the field of pharmaceuticals, particularly in the treatment of seizure disorders, underscore his role as an influential inventor. His innovative patents and ongoing research continue to pave the way for advancements in epilepsy treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile